Dong-Hoe Koo

12PUBLICATIONS
56CO-AUTHORS
ChemotherapyEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 22, 2026
Trastuzumab plus nivolumab with gemcitabine and cisplatin as first-line therapy for HER2-positive unresectable biliary tract cancer: a phase 1b/2 trial.

|Apr 06, 2026
Tumor-Associated Macrophage Infiltration and PD-L1 Expression in Gastric Cancer According to a Modified TCGA-Based Classification.

Boram Song, Dong-Hoe Koo, Eo Jin Kim

|Jan 17, 2025
Conversion Therapy for Stage IV Gastric Cancer: Report From the Expert Consensus Meeting at KINGCA WEEK 2024.

Tae-Han Kim, Ichiro Uyama, Sun Young Rha

|Oct 26, 2023
Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line Treatment of Advanced Gastric Cancer: K-Umbrella Gastric Cancer Study.

Choong-Kun Lee, Hyo Song Kim, Minkyu Jung

|Jun 26, 2023
Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric or Gastroesophageal Junction Cancer.

Chang Gon Kim, Minkyu Jung, Hyo Song Kim

|Apr 21, 2023
Progranulin and Breast Cancer Mortality: 13-Year Follow-Up of a Cohort Study.

Dong-Hoe Koo, Keun Seok Lee, Sung Hoon Sim

Pageof 2

Frequent Collaborators

4 joint publications

Choong-Kun Lee

4 joint publications

Sun Young Rha

3 joint publications

Dae Young Zang

2 joint publications

Hyo Song Kim